Total Payments
$22,339
2024 Payments
$1,070
Companies
67
Transactions
1,510
Medicare Patients
2,819
Medicare Billing
$377,424
Payment Breakdown by Category
Food & Beverage$21,990 (98.4%)
Education$349.23 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,990 | 1,487 | 98.4% |
| Education | $349.23 | 23 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,556 | 186 | $0 (2024) |
| ABBVIE INC. | $2,259 | 131 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,622 | 134 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,614 | 121 | $0 (2024) |
| Novo Nordisk Inc | $1,488 | 119 | $0 (2023) |
| PFIZER INC. | $1,357 | 115 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,045 | 63 | $0 (2024) |
| Allergan, Inc. | $825.28 | 68 | $0 (2020) |
| Amgen Inc. | $794.96 | 46 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $749.32 | 49 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,070 | 49 | ABBVIE INC. ($541.28) |
| 2023 | $3,525 | 211 | AbbVie Inc. ($809.73) |
| 2022 | $2,306 | 150 | ABBVIE INC. ($604.23) |
| 2021 | $2,488 | 161 | AstraZeneca Pharmaceuticals LP ($288.78) |
| 2020 | $2,257 | 145 | AstraZeneca Pharmaceuticals LP ($528.03) |
| 2019 | $2,804 | 209 | AstraZeneca Pharmaceuticals LP ($582.40) |
| 2018 | $4,267 | 305 | AstraZeneca Pharmaceuticals LP ($748.15) |
| 2017 | $3,621 | 280 | AstraZeneca Pharmaceuticals LP ($790.09) |
All Payment Transactions
1,510 individual payment records from CMS Open Payments — Page 1 of 61
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: VACCINE | ||||||
| 10/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.73 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.57 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2024 | Becton, Dickinson and Company | — | Food and Beverage | In-kind items and services | $22.61 | General |
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $30.20 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: DIABETES | ||||||
| 08/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: DIABETES | ||||||
| 07/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Insomnia | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/22/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/11/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Endocrinology | ||||||
| 06/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 559 | 994 | $231,829 | $84,051 |
| 2022 | 10 | 607 | 1,075 | $242,357 | $86,299 |
| 2021 | 15 | 870 | 1,424 | $266,572 | $113,619 |
| 2020 | 16 | 783 | 1,353 | $274,426 | $93,454 |
Total Patients
2,819
Total Services
4,846
Medicare Billing
$377,424
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 261 | 658 | $165,158 | $55,531 | 33.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 117 | 117 | $29,718 | $14,946 | 50.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 34 | 39 | $15,639 | $6,003 | 38.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 81 | $14,337 | $4,728 | 33.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 14 | $4,914 | $1,859 | 37.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 15 | 15 | $516.00 | $428.82 | 83.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 30 | 45 | $855.00 | $403.29 | 47.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 12 | $588.00 | $123.09 | 20.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 12 | 13 | $104.00 | $28.60 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 292 | 701 | $176,652 | $57,331 | 32.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 116 | 116 | $29,812 | $15,338 | 51.4% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 22 | 26 | $10,556 | $4,175 | 39.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 67 | $12,071 | $4,001 | 33.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 22 | $7,810 | $2,813 | 36.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 14 | 14 | $1,400 | $913.25 | 65.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 43 | 68 | $1,292 | $626.66 | 48.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 18 | 18 | $594.00 | $476.64 | 80.2% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 13 | 14 | $1,316 | $345.72 | 26.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 29 | $854.00 | $279.12 | 32.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 345 | 811 | $179,231 | $70,856 | 39.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 159 | 159 | $37,365 | $21,504 | 57.6% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 28 | 31 | $11,656 | $5,275 | 45.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 57 | 61 | $9,333 | $3,752 | 40.2% |
| 0031A | Adm sarscov2 vac ad26 .5ml | Office | 2021 | 85 | 85 | $4,845 | $3,471 | 71.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 24 | 24 | $6,982 | $2,410 | 34.5% |
About Jeremy Bearfield, MD, PHD
Jeremy Bearfield, MD, PHD is a Family Medicine healthcare provider based in Reno, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2011. The National Provider Identifier (NPI) number assigned to this provider is 1326337437.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jeremy Bearfield, MD, PHD has received a total of $22,339 in payments from pharmaceutical and medical device companies, with $1,070 received in 2024. These payments were reported across 1,510 transactions from 67 companies. The most common payment nature is "Food and Beverage" ($21,990).
As a Medicare-enrolled provider, Bearfield has provided services to 2,819 Medicare beneficiaries, totaling 4,846 services with total Medicare billing of $377,424. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Reno, NV
- Active Since 03/30/2011
- Last Updated 01/08/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1326337437
Products in Payments
- FARXIGA (Drug) $2,611
- VRAYLAR (Drug) $1,620
- JARDIANCE (Drug) $911.77
- Ozempic (Drug) $675.07
- XARELTO (Drug) $495.15
- LINZESS (Drug) $463.36
- Trintellix (Drug) $457.62
- XIFAXAN (Drug) $441.31
- ANORO (Drug) $392.58
- Victoza (Drug) $379.73
- CHANTIX (Drug) $355.65
- TRELEGY ELLIPTA (Drug) $351.48
- QULIPTA (Drug) $345.38
- UBRELVY (Drug) $345.06
- JANUVIA (Drug) $344.06
- SHINGRIX (Biological) $341.50
- VIBERZI (Drug) $322.04
- STIOLTO RESPIMAT (Drug) $314.77
- MYRBETRIQ (Drug) $305.92
- BREZTRI (Drug) $298.58
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Reno
Catherine Mccarthy, Md, MD
Family Medicine — Payments: $52,895
Family Medicine $52,895
Dr. Michael O'brien, Md, MD
Family Medicine — Payments: $22,320
Family Medicine $22,320
Dr. Vance Alm, Md, MD
Family Medicine — Payments: $18,168
Family Medicine $18,168
James Mclennan, Md Pc, MD PC
Family Medicine — Payments: $17,743
Family Medicine $17,743
Bayo Curry-Winchell, Md, MD
Family Medicine — Payments: $12,638
Family Medicine $12,638
Dr. Suraj Verma, M.d, M.D
Family Medicine — Payments: $12,462
Family Medicine $12,462